This is a highly targeted treatment approach using radioactive molecules aimed at destroying specific cancer cells without affecting other normal cells.
177Lu-based treatment options are available for Neuroendocrine tumors and prostate cancer. The latest addition is 225Ac-based theranostics.
NUCLEUZ HEALTHCARE PRIVATE LIMITED,TC 17/127(1&2), Ulloor Junction, Near Credence Hospital, Opposite Catholic Syrian Bank, Medical College P.O,
Thiruvananthapuram, Kerala 695011.